Drug Discovery From Nature 2000
DOI: 10.1007/978-3-642-60250-4_8
|View full text |Cite
|
Sign up to set email alerts
|

The Chemical Screening Approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
25
0

Year Published

2001
2001
2006
2006

Publication Types

Select...
8

Relationship

6
2

Authors

Journals

citations
Cited by 27 publications
(25 citation statements)
references
References 120 publications
0
25
0
Order By: Relevance
“…In the culture broth of Actinomyces sp. (strain Lu 9419), which was isolated from the intestines of a rose chafer (Cetonia aureata) we identified two novel aminocarba sugars, which were named cetoniacytone A (1) and B (2). Carba sugars and aminocarba sugars are widespread metabolites produced especially by actinomycetes.…”
mentioning
confidence: 99%
“…In the culture broth of Actinomyces sp. (strain Lu 9419), which was isolated from the intestines of a rose chafer (Cetonia aureata) we identified two novel aminocarba sugars, which were named cetoniacytone A (1) and B (2). Carba sugars and aminocarba sugars are widespread metabolites produced especially by actinomycetes.…”
mentioning
confidence: 99%
“…A detailed screening of the secondary metabolite pattern produced by different athropod associated strains of the species Streptomyces anulatus resulted in the isolation and structure elucidation of the endophenazines A-D (2,(4)(5)(6). The structures were assigned by spectroscopic methods and chemical transformations.…”
mentioning
confidence: 99%
“…Treatment of 249 with three primary amines (R 1 NH 2 ) yielded carbamates 250. For the incorporation of the second element of diversity (R 2 ) onto the spiroketal scaffold, the terminal olefin of 250 was previously converted to acid in three steps by osmylation, oxidative cleavage using Pb(OAc) 4 , and chlorite oxidation. The second diversity step was then accomplished using amide bond formation.…”
Section: Other Natural Productsmentioning
confidence: 99%
“…[1][2][3][4][5] Despite changing strategies in natural product research, in which concern sample selection and collection, isolation techniques, structure elucidation, biological evaluation, semisynthesis, dereplication, biosynthesis, as well as optimisation of downstream processing, 6,7 the rate of discovery of truly novel natural product drugs has actually decreased. 8 Reasons for this fact are related to high costs and time consuming of conventional programs in natural products, 9,10 which led to the exploitation of modern high-throughput screening and combinatorial strategies by the pharmaceutical industry, to generate new lead structures.…”
Section: Introductionmentioning
confidence: 99%